These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1901242

  • 1. Single step selection of cis-diamminedichloroplatinum(II) resistant mutants from a human ovarian carcinoma cell line.
    McLaughlin K, Stephens I, McMahon N, Brown R.
    Cancer Res; 1991 Apr 15; 51(8):2242-5. PubMed ID: 1901242
    [Abstract] [Full Text] [Related]

  • 2. Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II).
    Masuda H, Tanaka T, Matsuda H, Kusaba I.
    Cancer Res; 1990 Mar 15; 50(6):1863-6. PubMed ID: 2306738
    [Abstract] [Full Text] [Related]

  • 3. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
    Mamenta EL, Poma EE, Kaufmann WK, Delmastro DA, Grady HL, Chaney SG.
    Cancer Res; 1994 Jul 01; 54(13):3500-5. PubMed ID: 8012973
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.
    Andrews PA, Velury S, Mann SC, Howell SB.
    Cancer Res; 1988 Jan 01; 48(1):68-73. PubMed ID: 3335000
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells.
    Oguchi H, Kikkawa F, Kojima M, Maeda O, Mizuno K, Suganuma N, Kawai M, Tomoda Y.
    Anticancer Res; 1994 Jan 01; 14(1A):193-200. PubMed ID: 7909418
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.
    Chen G, Zeller WJ, Todorov DK.
    Anticancer Res; 1993 Jan 01; 13(5A):1269-75. PubMed ID: 8239496
    [Abstract] [Full Text] [Related]

  • 14. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
    Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, Knutsen T, McKoy WM, Young RC, Ozols RF.
    Cancer Res; 1987 Jan 15; 47(2):414-8. PubMed ID: 3539322
    [Abstract] [Full Text] [Related]

  • 15. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): mechanisms involved in the resistance.
    Beketić-Oresković L, Osmak M, Jaksić M.
    Neoplasma; 1994 Jan 15; 41(3):163-9. PubMed ID: 7935985
    [Abstract] [Full Text] [Related]

  • 16. [Relationship between cytochrome c-mediated caspase-3 activity and chemoresistance in cisplatin-resistant human ovarian cancer cell lines].
    Yang X, Zheng F, Xing H, Gao Q, Wang W, Lu Y, Wang S, Ma D.
    Zhonghua Zhong Liu Za Zhi; 2002 Nov 15; 24(6):544-7. PubMed ID: 12667321
    [Abstract] [Full Text] [Related]

  • 17. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
    Yang XK, Xing H, Zheng F, Gao QL, Wang W, Lu YP, Ma D.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar 15; 38(3):158-61. PubMed ID: 12816691
    [Abstract] [Full Text] [Related]

  • 18. Suppression of hREV1 expression reduces the rate at which human ovarian carcinoma cells acquire resistance to cisplatin.
    Okuda T, Lin X, Trang J, Howell SB.
    Mol Pharmacol; 2005 Jun 15; 67(6):1852-60. PubMed ID: 15758147
    [Abstract] [Full Text] [Related]

  • 19. Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells.
    Wasenius VM, Jekunen A, Monni O, Joensuu H, Aebi S, Howell SB, Knuutila S.
    Genes Chromosomes Cancer; 1997 Apr 15; 18(4):286-91. PubMed ID: 9087568
    [Abstract] [Full Text] [Related]

  • 20. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD, Zhang LX, Yue W, Zhu YF, Lu HJ, Liu X, Cen XT, Guan XY, Li CH.
    Ai Zheng; 2003 Apr 15; 22(4):337-45. PubMed ID: 12703984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.